Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Declinol is a healthcare company focused on providing solutions for individuals struggling with alcohol use disorder and excessive alcohol consumption. The company develops and markets a line of nutraceutical products designed to reduce alcohol cravings and support the body's recovery from long-term alcohol use. Their primary product, also named Declinol, utilizes a proprietary blend of natural ingredients that target the neurochemical pathways associated with addiction and withdrawal. By offering a non-prescription alternative to traditional pharmaceutical interventions, Declinol aims to provide a discreet and accessible option for managing alcohol dependency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Declinol.